Literature DB >> 22415380

Minimally invasive surgery for the lumbar spine.

S D Gandhi1, D G Anderson.   

Abstract

Minimally invasive spine surgery is a rapidly developing field that has the potential to decrease surgical morbidity and improve recovery compared to traditional spinal approaches. Minimally invasive approaches have been developed for all regions of the spine, but have been best documented for degenerative conditions of the lumbar spine. Lumbar decompression and lumbar interbody fusion are two of the most well-studied minimally invasive surgical approaches. This article will review both the rationale and technique for minimally invasive lumbar decompression and for a minimally invasive transforaminal lumbar interbody fusion (TLIF).

Mesh:

Year:  2012        PMID: 22415380

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  3 in total

1.  Disc space preparation in transforaminal lumbar interbody fusion: a comparison of minimally invasive and open approaches.

Authors:  Jeffrey A Rihn; Sapan D Gandhi; Patrick Sheehan; Alexander R Vaccaro; Alan S Hilibrand; Todd J Albert; David G Anderson
Journal:  Clin Orthop Relat Res       Date:  2014-06       Impact factor: 4.176

2.  Surgical data and early postoperative outcomes after minimally invasive lumbar interbody fusion: results of a prospective, multicenter, observational data-monitored study.

Authors:  Paulo Pereira; David Buzek; Jörg Franke; Wolfgang Senker; Arkadiusz Kosmala; Ulrich Hubbe; Neil Manson; Wout Rosenberg; Roberto Assietti; Frederic Martens; Giovanni Barbanti Brodano; Kai-Michael Scheufler
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

3.  Effect of percutaneous nucleoplasty with coblation on phospholipase A2 activity in the intervertebral disks of an animal model of intervertebral disk degeneration: a randomized controlled trial.

Authors:  Dajiang Ren; Zhicheng Zhang; Tiansheng Sun; Fang Li
Journal:  J Orthop Surg Res       Date:  2015-03-25       Impact factor: 2.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.